Mechanistic analysis reveals lineage plasticity drives resistance in a quarter of metastatic prostate tumors, highlighting potential strategies to restore drug sensitivity.
increasingly accepted mechanism of resistance in approximately a quarter of tumors involves lineage plasticity.
No takes yet. Share an insight, caveat, or question.
Leigh Ellis (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: